Key Takeaways
- Thyroid eye disease is an autoimmune condition that causes inflammation and swelling behind the eyes.
- Tepezza® (teprotumumab-trbw) is a monoclonal antibody infusion therapy specifically approved to treat thyroid eye disease by targeting the IGF-1 receptor.
- By blocking this immune pathway, Tepezza may reduce eye bulging (proptosis), improve double vision, and relieve pressure and pain.
- Treatment is given as a series of IV infusions over several weeks.
- Smart Infusion Therapy Services is an outpatient infusion center in Wisconsin providing Tepezza infusions in Eau Claire, Wausau, Madison, and Onalaska, WI, in a comfortable, patient-centered setting.
If you’re living with thyroid eye disease (TED), you may feel like your eyes no longer feel, or look, the way they used to. Swelling, pressure, double vision, or eye bulging can make everyday activities like reading, driving, or even making eye contact uncomfortable.
The good news is that treatment has advanced. Tepezza® (teprotumumab-trbw) is the first FDA-approved medication developed specifically to treat thyroid eye disease by targeting its underlying immune cause rather than just the surface symptoms.
Understanding Thyroid Eye Disease
Thyroid eye disease, sometimes called Graves’ orbitopathy, is a progressive autoimmune disorder in which the immune system mistakenly attacks tissues behind the eyes.
This immune response can cause:
- Inflammation
- Swelling of eye muscles and fatty tissue
- Increased pressure in the eye socket
- Tissue expansion
Over time, this may lead to:
- Eye bulging, also known as proptosis
- Redness and swelling
- Light sensitivity
- Double vision
- Eye pain or pressure
- Difficulty reading or driving
Because TED affects deeper tissues and immune pathways, it requires treatment that addresses the underlying cause rather than just surface symptoms.
Why Targeted Infusion Therapy Can Help
Lubricating eye drops may ease dryness, but they do not treat the immune-driven inflammation causing thyroid eye disease.
Infusion therapy delivers medication directly into the bloodstream in controlled doses. This allows treatment to reach the immune pathways responsible for swelling and tissue changes.
The goals of infusion therapy for TED include:
- Reducing inflammation behind the eyes
- Preventing further tissue enlargement
- Improving eye alignment and movement
- Slowing disease progression
One of the most advanced infusion therapies for thyroid eye disease is Tepezza.
How Tepezza Works
Tepezza is a monoclonal antibody that targets and blocks the insulin-like growth factor-1 receptor (IGF-1R), which plays a central role in the inflammatory process of thyroid eye disease.
The Role of IGF-1R in TED
Research shows that TED is strongly linked to overactivation of IGF-1R.
When IGF-1R becomes overactive:
- Immune cells trigger inflammation
- Orbital tissues retain fluid and expand
- Swelling and eye bulging increase
What Tepezza Does
Tepezza binds to and blocks IGF-1R. By interrupting this immune signaling pathway, Tepezza helps:
- Decrease inflammation behind the eyes
- Reduce tissue swelling
- Improve double vision
- Decrease proptosis, or forward eye bulging
- Relieve pressure-related discomfort
Rather than masking symptoms, Tepezza targets the biological mechanism driving thyroid eye disease.
What Studies Have Shown
Tepezza marked a major advancement in thyroid eye disease treatment.
Clinical research has shown that Tepezza can:
- Significantly reduce proptosis
- Improve double vision
- Reduce inflammation and pressure
- Improve eyelid positioning
- Help patients return to normal vision-related activities
Many patients notice visible improvements during the course of treatment. For some, these changes help restore not only comfort, but also confidence.
How Tepezza Fits Into Your Care Plan
Thyroid eye disease is often managed by a coordinated care team that may include:
- An endocrinologist to manage thyroid function
- An ophthalmologist to monitor eye health and disease progression
- A prescribing provider to order and oversee infusion therapy
- An outpatient infusion center to administer treatment
Tepezza may be recommended if you:
- Have active TED symptoms
- Are you experiencing progressive eye bulging
- Have double vision or pain with eye movement
- Have not responded adequately to corticosteroids or other therapies
| Treatment | What It Does | Limitations |
|---|---|---|
| Eye drops | Relieve dryness and irritation | Do not treat underlying inflammation |
| Steroids | Reduce short-term inflammation | Temporary benefit and potential side effects |
| Tepezza infusions | Block IGF-1R to reduce immune-driven swelling | Requires scheduled infusion visits |
Because Tepezza directly targets the immune pathway responsible for TED, it is considered a disease-modifying therapy rather than short-term symptom relief.
What to Expect During Tepezza Infusions
Starting infusion therapy can feel intimidating. Our goal is to make your experience calm, structured, and supportive.
Smart Infusion Therapy Services is an outpatient infusion center in Wisconsin specializing in the administration of physician-ordered biologic and specialty infusion therapies.
A referral or order from your endocrinologist, ophthalmologist, or prescribing provider is required before starting Tepezza. Our team can assist in coordinating documentation and insurance verification.
During Your Appointment
You can expect:
- A comfortable infusion chair or private room
- Care from trained infusion nurses
- Clinical monitoring throughout your infusion
- WiFi, entertainment, snacks, and beverages
- A relaxed, patient-centered environment
Tepezza is administered as a series of IV infusions spaced several weeks apart.
After Your Infusion
After each infusion, our clinical team communicates directly with your referring specialist or prescribing provider, sharing treatment documentation and updates to support coordinated care.
A Targeted Approach to Restoring Comfort and Confidence
Thyroid eye disease can affect both visual function and appearance. Tepezza offers a targeted therapy designed to reduce inflammation, improve eye alignment, and restore comfort over time.
Smart Infusion Therapy Services is an outpatient infusion center in Wisconsin providing Tepezza therapy in Eau Claire, Wausau, Madison, and Onalaska. If you are ready to explore whether Tepezza may be appropriate for you, schedule an appointment today.
Frequently Asked Questions
What is Tepezza?
Tepezza (teprotumumab-trbw) is a monoclonal antibody infusion therapy approved by the FDA to treat thyroid eye disease by blocking the IGF-1 receptor pathway that drives inflammation and tissue expansion.
How does Tepezza help thyroid eye disease?
Tepezza reduces inflammation behind the eyes, decreases eye bulging, improves double vision, and helps restore eye comfort by interrupting harmful immune signaling.
How many infusions are required?
Your neurologist or prescribing provider will determine your infusion schedule, but Tepezza is typically given as a series of infusions spaced several weeks apart.
Do I need a referral for Tepezza infusion therapy?
Yes. A referral or order from your endocrinologist, ophthalmologist, or prescribing provider is required. Smart Infusion Therapy Services can assist with coordination.
What amenities are available during treatment?
Smart Infusion Therapy Services offers comfortable seating, private rooms, WiFi, snacks, and beverages to support a positive outpatient infusion experience.
